Clearside Biomedical (NASDAQ:CLSD) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Clearside Biomedical (CLSD) operate in?

Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.

Open	$1.06
Close	$1.02
Volume / Avg.	226.78K / 740.59K
Day Range	$1.01 - $1.08
52 Wk Range	0.92 - 2.12
Market Cap	$80.39M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	2.46%
Days to Cover	3.09

Recent News

Clearside Biomedical's Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

Clearside Biomedical's CLS-AX Phase 2b trial for wet AMD met primary and secondary endpoints, showing stable vision and reduced injection frequency by 84% over 24 weeks, with no serious adverse events reported.

Vandana Singh

Why Is Clearside Biomedical Stock Gaining Today?

Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS Microinjector and strategic partnerships.

Vandana Singh

Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.06
Close	$1.02
Volume / Avg.	226.78K / 740.59K
Day Range	$1.01 - $1.08
52 Wk Range	0.92 - 2.12
Market Cap	$80.39M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	2.46%
Days to Cover	3.09

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Clearside Biomedical (CLSD) stock?

You can purchase shares of Clearside Biomedical (NASDAQ:CLSD) through any online brokerage.

View our list of the best stock brokerages

Who are Clearside Biomedical (CLSD) competitors?

Other companies in Clearside Biomedical’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Rani Therapeutics Hldgs (NASDAQ:RANI) and Nutriband (NASDAQ:NTRB).

What is the forecast, or price target, for Clearside Biomedical (CLSD) stock?

Clearside Biomedical has a consensus price target of $5.56.

What is the current price for Clearside Biomedical (CLSD)?

The stock price for Clearside Biomedical (NASDAQ: CLSD) is $1.06 last updated November 21, 2024 at 7:48 PM EST.

Does Clearside Biomedical (CLSD) pay a dividend?

There are no upcoming dividends for Clearside Biomedical.

When is Clearside Biomedical (NASDAQ:CLSD) reporting earnings?

Clearside Biomedical’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Clearside Biomedical (CLSD) going to split?

There is no upcoming split for Clearside Biomedical.

What sector and industry does Clearside Biomedical (CLSD) operate in?

Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Clearside Biomedical

Clearside Biomedical (CLSD) Forecast